NCT02922634

Brief Summary

The objectives of this study are to determine whether identifying patients with baseline cognitive deficits or frailty predict postoperative delirium.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
229

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2016

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 4, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

April 17, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 9, 2018

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2019

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

July 21, 2021

Completed
Last Updated

July 21, 2021

Status Verified

June 1, 2021

Enrollment Period

1.5 years

First QC Date

March 14, 2016

Results QC Date

February 26, 2021

Last Update Submit

June 30, 2021

Conditions

Keywords

postoperative health outcomesolder surgical patientsdelirium

Outcome Measures

Primary Outcomes (14)

  • Delirium by Age

    The median ages of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method. The Confusion Assessment Method (CAM) is a short diagnostic interview for CAM-defined delirium. Delirium is defined as the sudden change in someone's thinking ability that can have devastating consequences and can be very easily missed due to its frequent subtlety. The 4 CAM features assessed by the CAM include: acute onset or fluctuation, inattention, disorganized thinking, or altered level of consciousness.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by Sex

    Sex of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.

    up to 3 days post-op

  • Delirium by Body Mass Index

    Median body mass index of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by College Degree

    Counts of patients with a college degree who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.

    up to 3 days post-op

  • Participants With an ASA Physical Status Score and the Development of Postoperative Delirium

    The ASA Physical Status Classification System assesses and communicates a patient's pre-anesthesia medical co-morbidities and is on a scale of I-VI. This study recruited patients with an ASA physical status of I-III. ASA I is defined as a normal healthy patient, ASA II is defined as a patient with a mild systemic disease, ASA III is defined as a patient with severe systemic disease. ASA physical status of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by Metabolic Equivalent of Task Score < 4

    Patients with a metabolic equivalent of task (METS) score \< 4 who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method. The METS score is a ratio of the working metabolic rate relative to the resting metabolic rate and is one way to describe the intensity of an exercise or activity. This was assessed by the preoperative or surgical study staff. A score of \< 3 is for light intesity activities, 3-6 for moderate intensity activities, and ≥ 6 for vigorous intensity activities.

    up to 3 days post-op

  • Delirium by Total Number of Medications Taken at Baseline

    Median total number of medications of patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by Opioid Use

    Patients with chronic use of opioids who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by Alcohol Consumption

    Patients who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method based on alcohol consumption.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by Presence of Depression

    Patients with depression who did or did not develop post-operative delirium as assessed by the Confusion Assessment Method.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by Psychiatric History

    Patients with a history of psychiatric disorders who did or did not develop post-operative delirium as assessed by the confusion assessment method.

    up to 3 days post-op

  • Delirium by Mini-cog Score

    Median mini-cog score of patients who did or did not develop post-operative delirium as assessed by the confusion assessment method. The Mini-Cog is a brief cognitive screening test for visuospatial representation, recall, and executive function. The test involves that includes recalling three words (banana, sunrise, and chair) and a clock drawing. The Mini-Cog has a scale from 0 to 5, a with higher scores suggesting better cognitive performance. One point is designated for each of 3 words recalled and up to two points for the clock drawing component.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by FRAIL Score

    Robust, pre-frail, and frail patients who did or did not develop post-operative delirium as assessed by the confusion assessment method.

    up to 3 days post-op

  • Number of Participants With or Without Delirium by Surgical Invasivness

    Surgical invasiveness for patients who did or did not develop post-operative delirium as assessed by the confusion assessment method. The levels of invasiveness were categorized clinically as the following: Tier 1 for microdiscectomy, Tier 2 for lumbar laminectomy, anterior cervical, minimally invasive, foraminotomy, facetectomy, Tier 3 for lumbar fusion, trauma, and post-cervical, and Tier 4 for tumor, infection, deformity, and anterior and posterior cervical. Higher tiers indicate greater levels of invasiveness. Since there were very few patients with an invasiveness of 1 or 4 they were placed into two groups, with invasiveness levels I and 2 or 3 and 4.

    up to 3 days post-op

Secondary Outcomes (2)

  • Number of Participants With In-hospital Complications Were Observed During Their Length of Stay in the Hospital With Death Postoperative Death Monitored up to Day 30.

    duration of hospital stay, up to 30 days

  • Participants' Discharge Location (Home vs. Other Than Home)

    up to 30 days after the surgical procedure

Study Arms (1)

older surgical patients

Older surgical patients presenting for elective spine surgery

Other: Mini Cog

Interventions

short cognitive screen, short Frailty screen

Also known as: Frailty, Animal Fluency
older surgical patients

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

229 consenting subjects ≥ 70 years of age who present to the BWH Weiner Center for Preoperative Evaluation (CPE) prior to elective spine surgery.

You may qualify if:

  • patients 70 years of age and older presenting to the BWH Weiner Center for Preoperative Evaluation
  • undergoing elective spine surgery

You may not qualify if:

  • include planned ICU admission postoperatively
  • history of stroke or brain tumor
  • uncorrected vision or hearing impairment (unable to see pictures or read or hear instructions)
  • limited use of the dominant hand (limited ability to draw)
  • inability to speak, read, or understand English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weiner Center for Preoperative Evaluation

Boston, Massachusetts, 02115, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma

MeSH Terms

Conditions

Cognitive DysfunctionDelirium

Interventions

Mental Status and Dementia Tests

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Neuropsychological TestsPsychological TestsBehavioral Disciplines and Activities

Limitations and Caveats

Thirty percent of eligible patients declined participation in this study leading to potential selection bias based on the type of person who chooses to participate in such a study. There is also the possibility that we underestimated the prevalence of post-operative delirium because we only assessed patients for delirium once a day for 3 days post-op and by systematic chart review.

Results Point of Contact

Title
Dr. Gregory Crosby
Organization
BWH

Study Officials

  • Deborah Culley, M.D.

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

March 14, 2016

First Posted

October 4, 2016

Study Start

April 17, 2017

Primary Completion

October 9, 2018

Study Completion

June 9, 2019

Last Updated

July 21, 2021

Results First Posted

July 21, 2021

Record last verified: 2021-06

Locations